Frontage Holdings Corporation (HKG:1521)
1.390
-0.080 (-5.44%)
Aug 22, 2025, 3:41 PM HKT
Frontage Holdings Revenue
In the year 2024, Frontage Holdings had annual revenue of $254.91M USD, down -1.90%. Frontage Holdings had revenue of $126.43M in the half year ending December 31, 2024, a decrease of -3.80%.
Revenue
$254.91M
Revenue Growth
-1.90%
P/S Ratio
1.46
Revenue / Employee
$163.40K
Employees
1,560
Market Cap
2.89B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 254.91M | -4.95M | -1.90% |
Dec 31, 2023 | 259.86M | 9.50M | 3.79% |
Dec 31, 2022 | 250.36M | 65.92M | 35.74% |
Dec 31, 2021 | 184.44M | 58.63M | 46.60% |
Dec 31, 2020 | 125.81M | 25.40M | 25.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
CSPC Pharmaceutical Group | 28.99B |